Label: PR BENZOYL PEROXIDE WASH- benzoyl peroxide wash lotion

  • Category: HUMAN PRESCRIPTION DRUG LABEL

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated June 12, 2018

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

  • DESCRIPTION

    DESCRIPTION:
    PRTM Benzoyl Peroxide Wash is intended for topical administration and contains Benzoyl Peroxide for use in the treatment of acne vulgaris. Benzoyl Peroxide is an oxidizing agent that possesses antibacterial properties and is classified s a keratolytic. Benzoyl Peroxide (C14H10O4) is represented by the
    following chemical structure:
    O = C – O – O – C = O

    Each mL of PRTM Benzoyl Peroxide Wash contains 70 mg of Benzoyl Peroxide in an emulsion based formulation consisting of: aloe, carbomer 940, cetyl alcohol, disodium oleamido MEA-sulfosuccinate, disodium EDTA, glyceryl stearate/PEG-100 stearate, glycerin, green tea, laureth-12, magnesium aluminum silicate, propylene glycol, purified water, sodium coco-sulfate, sodium lauroamphoacetate, xanthan gum.

  • CLINICAL PHARMACOLOGY

    CLINICAL PHARMACOLOGY:
    The mechanism of action of Benzoyl Peroxide is not totally understood but its antibacterial activity against Propionibacterium acnes is thought to be a major mode of action. In addition, patients treated with Benzoyl Peroxide show a reduction in lipids and free fatty acids, and mild desquamation (drying and peeling activity) with simultaneous reduction in comedones and acne lesions. Little is known about the percutaneous penetration, metabolism, and excretion of Benzoyl Peroxide, although it has been shown that Benzoyl Peroxide absorbed by the skin is metabolized to benzoic acid and then excreted as benzoate in the urine. There is no evidence of systemic toxicity caused by Benzoyl Peroxide in humans.

  • INDICATIONS & USAGE

    INDICATIONS AND USAGE:
    PRTM Benzoyl Peroxide Wash is indicated for the topical treatment of acne vulgaris.

  • CONTRAINDICATIONS

    CONTRAINDICATIONS:
    PRTM Benzoyl Peroxide Wash is contraindicated in persons with a known hypersensitivity to any of its ingredients.

  • WARNINGS AND PRECAUTIONS

    WARNINGS:
    When using this product, avoid unnecessary sun exposure and use a sunscreen.
    PRECAUTIONS:
    General: For external use only. If severe irritation develops, discontinue use and institute appropriate therapy. After reaction clears, treatment may often be resumed with less frequent application. These preparations should not be used in or near the eyes or on mucous membranes.

  • INFORMATION FOR PATIENTS

    Information For Patients:
    Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. Contact with any colored material (including hair and fabric) may result in bleaching or discoloration. If excessive irritation develops, discontinue use and consult your physician.

  • CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

    Carcinogensesis, Mutagenesis, Impairment of Fertility:
    Data from several studies employing a strain of mice that is highly susceptible to developing cancer suggest that Benzoyl Peroxide acts as a tumor promoter. The clinical significance of these findings to humans is unknown. Benzoyl Peroxide has not been found to be mutagenic (Ames Test) and there are no published data indicating it impairs fertility.

  • PREGNANCY

    Pregnancy: Teratogenic Effects:
    Pregnancy Category C: Animal reproduction studies have not been conducted with Benzoyl Peroxide. It is not known whether Benzoyl Peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl Peroxide should be used by a pregnant woman only if clearly needed. There are no available data on the effect of Benzoyl Peroxide on the later growth, development and functional maturation of the unborn child.

  • ADVERSE REACTIONS

    ADVERSE REACTIONS:
    Allergic contact dermatitis and dryness have been reported with topical Benzoyl Peroxide therapy.

  • OVERDOSAGE

    OVERDOSAGE:
    If excessive scaling, erythema or edema occurs, the use of this preparation should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.

  • DOSAGE & ADMINISTRATION

    DOSAGE AND ADMINISTRATION:
    PRTM Benzoyl Peroxide Wash: Apply to affected areas once or twice a day, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather. Rinse thoroughly and pat dry. If excessive drying occurs, control by rinsing of cleanser sooner or using less often.

  • HOW SUPPLIED

    HOW SUPPLIED:
    PRTM Benzoyl Peroxide Wash is supplied in a 16 oz bottle, NDC 42546-145-16.

  • STORAGE AND HANDLING

    Store at controlled room temperature 20°-25° C (68°-77° F); excursions permitted to 15°-30°C (59°-86°F).
    Protect from freezing.

    KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

  • PRINCIPAL DISPLAY PANEL - 473 mL Bottle Box

    NDC 42546-145-16

    PR
    Benzoyl Peroxide
    Wash
    (7% Benzoyl Peroxide)

    TOPICAL ACNE THERAPY

    7%

    Rx only
    Net wt. 16 oz

    PRUGEN
    PHARMACEUTICALS

    PRINCIPAL DISPLAY PANEL - 473 mL Bottle Box
  • INGREDIENTS AND APPEARANCE
    PR BENZOYL PEROXIDE WASH 
    benzoyl peroxide wash lotion
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42546-145
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Benzoyl Peroxide (UNII: W9WZN9A0GM) (Benzoyl Peroxide - UNII:W9WZN9A0GM) Benzoyl Peroxide70 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    aloe (UNII: V5VD430YW9)  
    CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 4Q93RCW27E)  
    cetyl alcohol (UNII: 936JST6JCN)  
    DISODIUM OLEAMIDO MONOETHANOLAMINE SULFOSUCCINATE (UNII: 5M1101WGSY)  
    EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
    PEG-100 STEARATE (UNII: YD01N1999R)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    GREEN TEA LEAF (UNII: W2ZU1RY8B0)  
    laureth-12 (UNII: OAH19558U1)  
    magnesium aluminum silicate (UNII: 6M3P64V0NC)  
    propylene glycol (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    sodium coco-sulfate (UNII: 3599J29ANH)  
    sodium lauroamphoacetate (UNII: SLK428451L)  
    xanthan gum (UNII: TTV12P4NEE)  
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:42546-145-161 in 1 BOX10/26/2009
    1473 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/26/2009
    Labeler - PruGen, Inc. (929922750)
    Establishment
    NameAddressID/FEIBusiness Operations
    PHARMASOL CORPORATION065144289MANUFACTURE(42546-145)